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A major challenge faced by mobile health (mHealth) is identifying an evaluation technique which 
provides a rigorous evaluation while capturing the unique characteristics of the intervention. This 
study investigates traditional and emerging methods of mHealth evaluation, identifying existing 
gaps. This research is a useful first step towards developing an evaluation technique which will 
facilitate implementation and enable mHealth to reach its potential in accelerating socio-economic 
development, particularly in Low and Middle Income countries (LMICs). 
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Mobile health (mHealth) is defined as medical and public health practice supported by mobile 
devices, such as mobile phones, patient monitoring devices, personal digital assistants, and other 
wireless devices (World Health Organization, 2011). mHealth can be used in both public health 
and clinical medicine to improve healthcare systems, support healthcare professionals, and provide 
better health outcomes for patients (Burns, Keating, & Free, 2016; Davis, DiClemente, & Prietula, 
2016). mHealth involves the use of mobile devices capable of supporting audio, photography, 
geolocation, sensors, internet access, and third-party apps (Davis et al., 2016). However, there is 
little or no quality control or regulations ensuring the usability, accuracy or safety of these mHealth 
interventions (Boudreaux, Waring, Hayes, Sadasivam, Mullen, & Pagoto, 2014). 
The success of a mHealth intervention is dependent not only on the intervention components being 
safe and effective, but also on the end-user’s willingness and ability to use it, and the context within 
which it is being used (Chib, van Velthoven, & Car, 2014). As a result, clinical evaluations where 
the primary goal is to determine effectiveness in a controlled research environment are often 
lacking consideration of the many other, complex variables which are required in order for the 
intervention to be successful. A robust mHealth evaluation should examine multiple criteria, such 
as user feedback on the mHealth intervention, the robustness of the technology, user engagement 
strategies, and user interaction, in addition to ensuring safety and accuracy (White, Burns, Giglia, 
& Scott, 2017). 
A rigorous, mixed-methods approach is required to untangle the “why” and the “how” of mHealth 
interventions (Hatt, Chatterji, Miles, Comfort, Bellows, & Okello, 2015). Hatt et al. (2015) believe 
that global public health practitioners should use the most rigorous systematic approach to answer 





the “gold standard” approach to pharmaceutical evaluations and it is perceived by many to be the 
best mechanism for mHealth evaluation (Pham, Wiljer, & Cafazzo, 2016b). However in recent 
years, evaluation methods have been proposed that may serve as alternatives to the RCT but they 
are, as yet, unsuccessful in changing the perception that the RCT is the most suitable approach to 
mHealth evaluation. Indeed, Pham et al. (2016b) noted that at no time throughout their study were 
alternative methodologies to the RCT mentioned as being more suitable for mHealth evaluation. 
Medical research also produces non-medical social effects such as increased productivity, greater 
competitiveness and economic growth. As a consequence, health-related research thereby 
contributes indirectly to a country’s Gross Domestic Product (Roback, Dalal, & Carlsson, 2011). 
In order for mHealth research to have the greatest impact on socio-economic development, it is 
important that fit-for-purpose techniques are used to adequately evaluate interventions. Effective 
evaluations aid in minimising resource wastage and maximising the development potential of 
mHealth (van Velthoven, Car, Zhang, & Marušić, 2013). With this in mind, the research question 
posed for this study is: “How can we characterize novel and existing approaches to mHealth and 
what gaps exist in these approaches?” In order to satisfy this question, we examine the traditional 
method, and identify three newly emerging methods of mHealth evaluation, outlining a 
comprehensive comparison between the characteristics of each methodology, and the challenges 
posed by the unique field of mHealth. The evaluation considers the Randomized Controlled Trial 
(RCT), the Continuous Evaluation of Evolving Behavioral Interventions Technologies (CEEBIT), 
the Multiphase Optimization Strategy (MOST) and the Sequential Multiple Assignment 
Randomized Trial (SMART). By gaining a greater understanding of these evaluation approaches, 
we endeavor to identify the gaps in the existing approaches and highlight the requirements for the 





This article is structured as follows. The next section presents a review of the literature including 
the benefits of employing mHealth, and the impact this has on socio-economic development. The 
following section considers the literature search methodology, and the development of the 
comparison criteria. Subsequently, a brief overview of each evaluation methodology is presented, 
followed by a table outlining the comparison of each. Finally, a comprehensive discussion of the 
methodology comparison is considered, followed by the conclusions.  
Literature Review 
mHealth Benefits 
With the rapidly shifting demographic and health profile of high-income countries to an ageing 
population with increasing chronic diseases, care is moving from hospital to community settings 
(Health Service Executive, 2017). There is an increasing focus on making care more patient-centric 
and empowering patients to manage their own care (Shankar, Prasad, Ankur, Talwar, & Jain, 
2013). This patient empowerment movement has seen an exponential rise in the development of 
mHealth interventions, many of these are freely available to download (IMS Institute for 
Healthcare Informatics, 2015). These interventions allow the patient to take charge of their own 
healthcare, supporting them in many areas of their health including; medication reminders, 
women’s health and pregnancy support, fitness and lifestyle, diet and nutrition, mental health and 
stress management (IMS Institute for Healthcare Informatics, 2015). 
Health gains in society may result in improved diet and living conditions, safer work environments 
and healthier lifestyles (Roback et al., 2011). mHealth has the potential to have a profound impact 
on socio-economic development in several ways, including influencing patient behaviour, 





clinical decisions. It is estimated that mHealth could save €99 billion in healthcare costs in the 
European Union alone (Shankar et al., 2013). In order to achieve this, demonstrable efficacy, cost-
effectiveness and accessibility must be prioritized alongside technical software development (The 
Lancet, 2017). Yet, the challenge remains in identifying an evaluation technique which can achieve 
these aspects, while keeping pace with the technology industry. Consequently, without a robust 
evidence base, mHealth will not become part of government policy at a fast pace, nor will policy-
makers be aware of its possible application (World Health Organization, 2011). 
Many mHealth interventions are being used in Low-to-Middle Income Countries (LMICs) or 
developing countries (Chib, 2018), where the potential for socio-economic development is far 
greater than in more developed regions. Although there is vast potential for mHealth to have 
meaningful benefits for socio-economic development such as improving disease management, 
health outcomes, and reducing disease burden, these are yet to be adequately evaluated (Nilsen, 
Kumar, Shar, Varoquiers, Wiley , Riley, Pavel, & Atienza, 2012), especially in LMICs (Chib et 
al., 2014; Hamine, Gerth-Guyette, Faulx, Green, & Ginsburg, 2015). Countries moving from a 
developing to developed status typically have low standards of living, a weak industrial and 
commercial base and poor infrastructure (Kowal & Paliwoda-Pękosz, 2017). Investment in 
Information and Communication Technology (ICT) correlate strongly with indicators of economic 
growth (Kowal et al., 2017). Most mHealth interventions considered successful in LMICs are 
based in Non-Governmental Organizations and not integrated into mainstream public health 
services (Mechael, Batavia, Kaonga, Searle, Kwan, Goldberger, Fu, & Ossman, 2010).  
mHealth and Socio-Economic Development 
With both developed and developing countries leveraging mHealth, developing countries have a 





accessible healthcare services. mHealth interventions have the potential to contribute to socio-
economic development in LMICs. Madon (2000) discusses four main dimensions of socio-
economic development; 1. Social wellbeing, 2. Physical environment, 3. Economic growth, and 4. 
Political wellbeing. In the following sections, we outline how mHealth interventions which are 
well designed, effectively evaluated, and successfully implemented and sustained, can advance the 
socio-economic development of developing countries.  
Social Wellbeing 
The most obvious merits of mHealth lie in the area of health improvement. Many interventions 
have the potential to contribute to improvements in a variety of health areas including; mental 
health (Burns, Begale, Duffecy, Gergle, Karr, Giangrande, & Mohr, 2011; Naslund, Marsch, 
McHugo, & Bartels, 2015), sexual health (Burns et al., 2016), and maternal health (Stephani, 
Opoku, & Quentin, 2016). mHealth contributes to patient empowerment by allowing self-
management of chronic diseases such as diabetes (Holmen, Torbjornsen, Wahl, Jenum, Smastuem, 
Arsand, & Ribu, 2014) and HIV/AIDS (Déglise, Suggs, & Odermatt, 2012), and connecting 
communities of support for people with similar experiences, such as breastfeeding families (White 
et al., 2017). mHealth also allows the removal of physical and financial barriers to healthcare, by 
allowing remote access to health information and contact with healthcare professionals (Opoku, 
Scott, & Quentin, 2015; Rutledge, Kott, Schweickert, Poston, Fowler, & Haney, 2017).   
Economic Growth 
Patients who are empowered are more likely to be motivated to manage their disease and adhere 
to medications (Brown & Bussell, 2011). This in turn contributes to an improvement in overall 
health outcomes and an increase in productivity due to fewer days lost at work due to illness (Khan 





mHealth as a diagnostic tool can result in a cheaper and faster health assessment process 
(Matthews, Kulkarni, Whitesides, Sarrafzadeh, Gerla, & Massey, 2009; Bourouis, Zerdazi, Feham, 
& Bouchachia, 2013), resulting in higher quality data recording than paper-based tools (Hall, 
Fottrell, Wilkinson, & Byass, 2014). The use of mHealth can also contribute to streamlined 
processes for Health Care Workers (HCWs), and improved communication between HCWs (Hall 
et al., 2014). 
Physical Environment 
mHealth interventions can facilitate instant data transfer allowing faster diagnosis, and can provide 
safer online or cloud storage of sensitive health data (Steinhubl, Muse, & Topol, 2015). Supply 
chain management is a problem in developing countries, with long delays in reporting and 
subsequent restocking of stock-outs, something that could be overcome by the implementation of 
mHealth interventions (Shieshia, Noel, Andersson, Felling, Alva, Agarwal, Lefevre, Misomali, 
Chimphanga, & Nsona, 2014). Particularly in developing nations with poor infrastructure, physical 
access to a health facility or contact with a HCWs can take many hours and requires traveling long 
distances. For example in Niger, less than a quarter of the population are within a 1-hour walk of 
a health center during the wet season (Blanford, Kumar, Luo, & MacEachren, 2012). mHealth can 
bridge this physical distance by connecting patients with HCWs, and with larger health facilities 
providing remote advice and care to people in need (Mahmud, Rodriguez, & Nesbit, 2010).  
 
Political Wellbeing 
Many African and Middle-Eastern countries continue to criminalize homosexuality (Cameron & 





imprisonment (Beyrer, 2014). This has been attributed to exacerbating the HIV epidemic in 
developing countries (Hagopian, Rao, Katz, Sanford, & Barnhart, 2017). As a result of this 
political standpoint, men who have sex with men living in these countries are perhaps the most 
vulnerable population in terms of contraction of HIV, subject to stigmatization and inability to 
access appropriate care. The use of mHealth can enable this vulnerable population to access 
confidential information and advice, test results, appointment scheduling and medication 
reminders (Catalani, Philbrick, Fraser, Mechael, & Israelski, 2013). mHealth interventions have 
shown successes in both the prevention and management of HIV in resource-poor settings 
(Catalani et al., 2013; Devi, Syed-Abdul, Kumar, Iqbal, Nguyen, Li, & Jian, 2015).   
mHealth in LMICS 
While the use of mHealth can provide profound opportunities (Nilsen et al., 2012; Davey & Davey, 
2014), research into the assessment of mHealth from a developing country perspective has been 
limited (Tariq & Akter, 2011; Peiris, Praveen, Johnson, & Mogulluru, 2014). The proliferation of 
lightweight mHealth interventions which fail to translate or scale into health systems has led to 
subsequent criticisms of “pilotitis” which plague the mHealth field (Labrique, Vasudevan, Chang, 
& Mehl, 2013, p. 468). The novelty of the field of mHealth in LMICs may partly explain why 
there has been a focus on pilot studies, many of which have not been followed up with rigorous 
evaluation, or taken to scale (Hall et al., 2014). Additionally, premature scale-up of an unevaluated 
mHealth intervention could harm the entire field (Chib et al., 2014). We need to reduce the plague 
of “pilotitis” and ensure the integrity of mHealth as a discipline. This can be achieved through the 
use of rigorous evaluation methodologies which will achieve a fuller understanding of the 
sustainability, scalability and usability of mHealth beyond early phases (Labrique et al., 2013; 





Ineffective Evaluation Impacting Potential 
The potential for mHealth to contribute to socio-economic development is clear. In order for this 
to be realised, mHealth interventions must be adequately evaluated using techniques which include 
research, design and analysis planning which is fit-for-purpose (Istepanian & Woodward, 2017). 
Pham et al. (2016b) argue that most mHealth interventions that make it to the evaluation stage are 
evaluated in a RCT. This has lead to an “all or nothing” situation, resulting in a grey area 
surrounding the efficacy and safety of publicly available mHealth interventions. Although many 
health ICT usability studies have been conducted to explore usability requirements, discover 
usability problems and design solutions, few of the studies reported have evaluated the usability 
of mobile technologies (Brown III, Yen, Rojas, & Schnall, 2013). Additionally, it is argued that 
mHealth evaluation is not a solitary activity but instead, should involve a range of stakeholders 
including developers, consumers, policy makers, and physicians to ensure the clinical viablity of 
the application (The Lancet, 2017). This is imperative as another challenge facing the evaluation 
of mHealth lies in the subjectivity of evaluation. mHealth projects often involve a large number of 
stakeholders from different backgrounds and disciplines. It is likely that individual goals for the 
project may differ between stakeholders and may lead to discrepancies in what constitutes a 
“successful” intervention (Heeks, 2002). A rigorous and reliable evaluation technique is required 
that will counter this challenge. 
Healthcare systems already face excessive costs and poor outcomes, so the adoption of 
unevaluated mHealth interventions may have a detrimental effect, exacerbating the problems 
(Kumar, Nilsen, Abernethy, Atienza, Patrick, Pavel, Riley, Shar, Spring, Spruijt-Metz, Hedeker, 
Honavar, Kravitz, Lefebvre, Mohr, Murphy, Quinn, Shusterman, & Swendeman, 2013). The 





of appropriate evaluation frameworks (Déglise et al., 2012; Kumar et al., 2013; Hall et al., 2014; 
Pham et al., 2016b). In the context of patient safety and security, the absence of effective evaluation 
has the potential to damage the field of mHealth by allowing sub-standard technologies and 
applications into the public domain which may cause substantial harm and conclude in future 
litigation (Rahman, 2015). The lack of evaluation across the mHealth field as a whole is a major 
weakness and threatens the credibility of mHealth as a concept (Hall et al., 2014). Rigorous 
evaluation of mHealth interventions is essential not only to quantify their effect, but to ensure that 
they do no harm (Pagoto & Bennett, 2013).   
Governments and health departments are becoming more interested in mHealth, with eHealth and 
mHealth being included in strategic plans (Leon, Schneider, & Daviaud, 2012; Njoroge, Zurovac, 
Ogara, Chuma, & Kirigia, 2017). This is a positive move for mHealth, so it is more important than 
ever for policy makers to make informed decisions and allocate resources to only the highest 
quality mHealth interventions. mHealth interventions have an enormous potential to accelerate 
socio-economic development in developing countries. However, so little evidence is available on 
the feasibility, acceptability, and effectiveness of mHealth, that many have not been taken to scale, 
remaining at the pilot phase (Labrique et al., 2013; Hall et al., 2014; Shuchman, 2014). Without 
an evaluation framework that is fit-for-purpose, the field cannot move forward and fulfil its 
potential to impact on social wellbeing, economic growth, physical environment, and political 
wellbeing (Cohen, Bancilhon, & Grace, 2018).  
mHealth evaluations have been criticized for often lacking the scientific rigor of the RCT, 
(Stephani et al., 2016) and the current evidence on their effectiveness is not convincing enough for 
policy-makers (Chib et al., 2014). Of note, the Food and Drug Administration (FDA) only began 





this, many mHealth interventions still fell outside of the remit of FDA monitoring and were not 
subject to regulation, whereas many others were subject to stringent regulation which hampered 
the development of potentially useful software (Malvey & Slovensky, 2017). Recently, the FDA 
have made the decision to demarcate the boundaries of applications which pose a low risk and do 
not meet their definition of medical devices (Taylor, 2017; US Food and Drug Adminstration, 
2017). This change of regulation by the FDA may also indicate that mHealth interventions no 
longer qualifying as a medical device, may not require a RCT evaluation. This may contribute to 
changing the perception that the RCT is best for mHealth interventions. However, a problem still 
remains as no rigorous and reliable alternative to the RCT has yet been identified. 
The RCT is considered to be the “gold standard” for the evaluation of interventions, and has 
subsequently been adopted into the mHealth field  (Burns et al., 2016; Pham et al., 2016b; Stephani 
et al., 2016). However, much of the literature around the topic has suggested that this methodology 
may be incompatable with mHealth, identifying weaknesses such as the lack of qualitative 
analysis, high resource cost, and lengthy timeframe (Nilsen et al., 2012; Kumar et al., 2013; Ben-
Zeev, Scheuller, Begale, Duffecy, Kane, & Mohr, 2015; Hatt et al., 2015; Pham et al., 2016b; 
White et al., 2017). From these weaknesses, a comparison criteria was derived against which to 
compare the RCT with novel evaluation technologies; 1. Data collection and analysis, 2. Standard 
execution protocol, 3. Sample size, 4. Cost, 5. Protocol, and 6. Time (Kaplan, 2001; Nilsen et al., 
2012; Kumar et al., 2013; Ben-Zeev et al., 2015; Pham et al., 2016b). These criteria are used to 
compare the evaluation methodologies and identify gaps in their processes in the context of 
mHealth evaluation. 
The evaluation of mHealth interventions presents several unique challenges; particularly the rapid 





and the complexity of mHealth interventions, requiring a mixed-method evaluation to capture all 
of the socio-technical aspect of the intervention (Kaplan, 2001; Hatt et al., 2015; Pham et al., 
2016b). Additionally, Pham et al. (2016b) identified three weaknesses of the RCT in relation to 
mHealth evaluation. These include 1. The high cost of trial implementation, 2. The rigid protocol 
of the RCT and 3. The issue of blinding. Together, these mHealth challenges and RCT weaknesses 
were used to develop the comparison criteria for the methodologies used in this study.  
This study aims to examine the mHealth evaluation literature to compare the characteristics of 
each technique, and the criteria identified for successful mHealth evaluation and to identify novel 
evaluation techniques which may provide an alternative to the RCT. 
Methodology 
This study was conducted as part of a larger research project. PubMed, Google Scholar, and the 
AIS library were searched in January 2017 using search terms under the pillars of “mHealth” and 
“evaluation.” The mHealth literature has indicated that the most robust evalution of mHealth 
should conduct mixed-method evaluation (Kaplan, 2001; Hatt et al., 2015; Pham et al., 2016b) 
therefore, records were included if they: 1. Utilised a mixed-method evaluation, 2. Described a 
single application or intervention, 3. Described a pilot evaluation, 4. Provided guidance for 
evaluation. Records were excluded if they: 1. Used a single method evaluation (e.g. examined only 
effectiveness/efficacy, or only usability/acceptability), 2. Conducted a review of existing mHealth 
interventions, 3. Described a protocol, 4. Described health data, 5. Conducted post-hoc reviews or 
assessments of quality (i.e. after implementation). Due to the large number of records, only the 
first 5 pages of Google Scholar were retrieved. Saturation point was quickly reached as the 
majority of records identified up to this point were duplications of records found in PubMed, with 





included papers which focused on the pilot stage of implementation. Implementation refers to the 
“effort directed toward diffusing appropriate Information Technology (IT) within a user 
community” (Cooper and Zmud 1990, p.124). There is a lack of consensus, however, on the 
number of stages involved with IT implementation (Thompson, 1969; Pierce & Delbecq, 1977; 
McFarlan & McKenney, 1982; Cooper et al., 1990). For the purpose of this study, a pilot 
implementation is defined as: “a field test of a properly engineered, yet unfinished system, in its 
intended environment, using real data and aiming – through real-use experience – to explore the 
value of the system, improve or assess its design, and reduce implementation risk.” (Hertzum, 
Bansler, Havn and Simonsen, 2012, p.2). Focusing on this stage of implementation (i.e. pilot study) 
is integral to allowing us to characterize and identify the gaps in approaches to mHealth evaluation, 
to fulfill the requirements of sustainable, scalable and usable mHealth interventions in LMICs.  
Following the literature search, the titles and abstracts of 236 records were screened for eligibility. 
111 records met the eligibility criteria, and were retrieved and reviewed. 84 studies were excluded 
as they were deemed irrelevant, and 26 studies were included. Of these, 16 utilised a mixed-method 
evaluation, and 10 provided guidance for evaluation. Full details of the search process are outlined 






Figure 1 – Literature Search Process 
 
  
The studies utilising mixed-method evaluations were examined to determine the methodology 
used. The evaluation techniques used in each of these studies is listed in Table 1. We found that 





This is reflective of the lack of standardised, widely accepted evaluation frameworks for mHealth 
evaluation as identified in the literature (Déglise et al., 2012; Kumar et al., 2013; Hall et al., 2014).  
Table 1 – Mixed Method Evaluation Techniques of Included Studies 
Mixed Method Evaluation 
Pre-post study with interviews or focus 
groups 
5 (Cafazzo, Casselman, Hamming, Katzman, & Palmert, 
2012; Lemay, Sullivan, Jumbe, & Perry, 2012; Battle, 
Farrow, Tibaijuka, & Mitchell, 2015; Ho, Newton, 
Boothe, & Novak-Lauscher, 2015; Vu, Nguyen, Tran, & 
Muhajarine, 2016) 
Cluster RCT with interviews 2 (Chang, Kagaayi, Arem, Nakigozi, Ssempijja, Serwadda, 
Quinn, Gray, Bollinger, & Reynolds, 2011; Jamison, 
Karlan, & Raffler, 2013) 
Post-task questionnaire with interviews 2 (Lim, Cloete, Dunsmuir, Payne, Scheffer, von 
Dadelszen, Dumont, & Ansermino, 2015; Braun, 
Lasway, Agarwal, L'Engle, Layer, Silas, Mwakibete, & 
Kudrati, 2016) 
Uncontrolled trial with usability 
questionnaire 
2 (Mohr, Montague, Stiles-Shields, Kaiser, Brenner, 
Carty-Fickes, Palac, & Duffecy, 2015; Ha, Tesfalul, 
Littman-Quinn, Antwi, Green, Mapila, Bellamy, Ncube, 
Mugisha, & Ho-Foster, 2016) 
RCT with user evaluation 1 (Pham, Khatib, Stansfeld, Fox, & Green, 2016a) 
Randomized crossover with 
acceptability questionnaire 
1 (Dahlberg, Jaensson, Eriksson, & Nilsson, 2016) 
Multiphase Optimization Strategy 1 (Buman, Epstein, Gutierrez, Herb, Hollingshead, 
Huberty, Hekler, Vega-López, Ohri-Vachaspati, & 
Hekler, 2015) 
Randomized trial with feedback 1 (McClure, Anderson, Bradley, An, & Catz, 2016) 
Comparative analysis with focus groups 1 (Neupane, Odendaal, Friedman, Jassat, Schneider, & 
Doherty, 2014) 
 
We then analysed the ten papers which provided guidelines and recommendations to identify novel 
mHealth evaluation methodologies. The papers were coded by one researcher, and ten distinct 
methodologies were identified. These are presented in Table 2. The evaluation methdologies 
mentioned most frequently were the MOST (n=5), SMART (n=4), and the CEEBIT (n=4). Due to 





principles of existing study design and the Mobile App Rating Scale (MARS)) were not included 
in the comparison.  
Table 2 – Guidelines and Recommendations for Alternative mHealth Evaluation 
Guidelines & Recommendations for mHealth Evaluation 
Multiphase Optimization Strategy (MOST) 5 (Nilsen et al., 2012; Whittaker, Merry, Dorey, & 
Maddison, 2012; Kumar et al., 2013; Pham et al., 
2016b; Buscemi, Janke, Kugler, Duffecy, 
Mielenz, George, & Gorin, 2017) 
Sequential Multiple Assignment Randomized 
Trial (SMART) 
4 (Nilsen et al., 2012; Kumar et al., 2013; Pham et 
al., 2016b; Buscemi et al., 2017) 
Continuous Evaluation of Evolving Behavioral 
Intervention Technologies (CEEBIT) 
4 (Kumar et al., 2013; Mohr, Schueller, Riley, 
Brown, Cuijpers, Duan, Kwasny, Stiles-Shields, 
& Cheung, 2015; Pham et al., 2016b) 
Evaluation utilizing principles of existing study 
designs (e.g. n-of-1, stepped-wedge RCT) 
3 (Nilsen et al., 2012; Whittaker et al., 2012; Pham 
et al., 2016b; White et al., 2017) 
Mobile Application Rating Scale (MARS) 2 (Stoyanov, Hides, Kavanagh, & Wilson, 2016; 
White et al., 2017) 
Integrate, Design, Assess and Share (IDEAS) 
Framework 
1 (Mummah, Robinson, King, Gardner, & Sutton, 
2016) 
ResearchKit 1 (Pham et al., 2016b) 
Micro-randomized trial 1 (Pham et al., 2016b) 
Meaningful Use Criteria 1 (Song, Kim, & Yi, 2013) 
Collaborative Adaptive Interactive Technology 1 (White et al., 2017) 
 
The following section presents an overview of the methodology of each of the four evaluation 
techniques, and is followed by Table 3 which compares each evaluation technique against the 
criteria required for successful mHealth evaluation.  
Findings 
Randomized Controlled Trial (RCT) 
The RCT is a trial in which subjects are randomly assigned to one of two groups: one (the 





group or control) receiving an alternative (conventional or placebo) treatment (Kendall, 2003). All 
intervention groups are treated identically except for the experimental treatment (Sibbald & 
Roland, 1998). The two groups are then followed up to see if there are any differences between 
them in outcome. The results and subsequent analysis of the trial are used to assess the 
effectiveness of the intervention, which is the extent to which a treatment, procedure or service 
does more good than harm (Kendall, 2003). 
RCTs are considered to be the “gold standard” for examining the effectiveness of a medical 
intervention in a clinical domain due to their ability to control for confounding factors and bias 
(Kendall, 2003). Calls for greater rigor in evaluation has increased the number of mHealth RCTs 
conducted in developed and developing countries (Burns et al., 2016). The majority of mHealth 
researchers are continuing to use the RCT for evaluating mHealth interventions, suggesting that 
researchers view this design to be the “gold-standard” for any clinical trial evaluating intervention 
efficacy (Pham et al., 2016b). 
Continuous Evaluation of Evolving Behavioral Intervention Technologies (CEEBIT) 
Behavioral Intervention Technologies (BITs) are web-based and mobile interventions intended to 
support patients and consumers in changing behaviors related to health, mental health and well-
being (Mohr, Cheung, Schueller, Brown, & Duan, 2013). CEEBIT is an evaluation method 
involving the deployment of substantively new versions of an intervention along with the previous 
version, with users randomized to available versions. The most efficacious version, based on a 
priori criteria, is retained (Kumar et al., 2013). This framework was proposed by Mohr et al. (2013) 





This methodology addresses the current weak evidence base and lack of discussion addressing 
how to evaluate interventions effectively and efficiently, and provides a solution to the challenge 
of rapid change, evolution and expanding expectations (Mohr et al., 2013). CEEBIT is suitable for 
the ongoing evaluation of interventions as they go to scale, adapting to the changing technological 
landscape and allowing for intervention improvement over time (Kumar et al., 2013). The method 
is statistically powered to continuously evaluate intervention efficacy and accounts for updated 
versions through a sophisticated elimination process (Pham et al., 2016b). 
Multiphase Optimization Strategy (MOST) 
MOST uses a principled method for identifying which components are active in an intervention 
and which levels of each component lead to the best outcomes. Its underlying principles are drawn 
from engineering and emphasize efficiency (Collins, Murphy, & Strecher, 2007). Promising 
components of an intervention are identified in a screening phase through either factorial or 
fractional factorial analysis of variance design (Kumar et al., 2013). MOST uses three phases as a 
replacement for the cycle of confirmatory trial, exploratory analysis, revision and subsequent 
confirmatory trial (Collins, Murphy, Nair, & Strecher, 2005). The final, optimized intervention is 
then evaluated in a standard RCT in the confirming phase to evaluate efficacy (Collins et al., 2007). 
The traditional approach to intervention development has involved constructing an intervention a 
priori and then evaluating it in a standard RCT, after which, post-hoc analyses are done and 
adjustments are made (Collins et al., 2007). MOST is a system aimed at creating an optimal version 





Sequential Multiple Assignment Randomized Trial (SMART) 
The SMART approach is a randomized experimental design that has been developed especially 
for building time-varying adaptive interventions (Collins et al., 2007). It allows investigators to 
evaluate the timing, sequencing, and adaptive selection of treatments in a principled fashion by 
use of randomized data (Almirall, Compton, Gunlicks-Stoessel, Duan, & Murphy, 2012). All 
questions within the SMART trial are addressed by means of randomized experiments and the end 
goal of the SMART approach is the development of evidence-based adaptive intervention 
strategies which are then evaluated in a subsequent RCT (Collins et al., 2007). 
The SMART approach considers the order of components in an intervention, as opposed to 
considering each component in isolation (Collins et al., 2007). Researchers decide which aspects 
of treatment require investigation and then individuals are randomly assigned to various 
intervention choices over time (Kumar et al., 2013). With this approach, a number of important 
treatment questions can be answered; the optimal length of the intervention, the best approach to 
take for treatment of non-responders and the level of support required for individuals (Clough et 
al., 2015). The SMART technique can be integrated into the MOST procedure, or be used as a 
stand-alone technique (Collins et al., 2007).  
The following section presents a comprehensive comparison of the four evaluation techniques 
outlined previously. This is followed by an in-depth discussion of how each evaluation technique 
meets the unique characteristics of mHealth. 
Comparison of Evaluation Techniques 
Table 3 outlines the main characteristics of each evaluation technique in a comparison of their 





choosing an evaluation technique as they examine both protocol-related factors, including standard 
execution and data collection techniques as well as logistical, resource requirement factors such as 







Table 3 - Comparison of Evaluation Techniques 
 





Quantitative analysis - The 
analysis is focused on 
estimating the size of 
difference in predefined 
outcomes (Sibbald & 
Roland 1998). 
Collects outcome and use data 
in real time. CEEBIT 
capitalizes on data generates 
by BITs to continuously 
evaluate efficacy in a manner 
consistent with the current 
socio-technologic 
environment (Mohr et al., 
2013). 
A key feature of MOST is that 
each new intervention produced 
will have been engineered, and 
empirically demonstrated, to be 
an improvement over the 
previous version (Collins, 
Nahum-Shani, & Almirall, 
2011b). 
SMART designs provide a 
framework to empirically 
determine the most powerful 
version of an intervention 
(Clough et al., 2015).  However, 
the SMART design does not 
compare the intervention to a 
control or comparative treatment 
condition (Clough et al., 2015). 
mHealth literature suggests the 
need for mixed-method 
evaluation to accurately capture 
the socio-technical reasons for 





Double blinding (usually 
investigator and 
participants) is the usual 
standard and will eliminiate 




In instances when non-
randomized assignment 
methods are warranted, 
statistical methods can 
mitigate overt bias when all 
confounding factors are 
observed (Mohr et al., 2013). 
Based on randomized 
experimentation, meaning that a 
high degree of confidence can 
be placed on the results (Collins 
et al., 2007). 
 
Based on randomized 
experimentation, placing a high 
degree of confidence on the 
results (Collins et al., 2007). To 
avoid information bias, the use of 
a blinded, independent evaluator 
is suggested (Almirall, Nahum-
Shani, Sherwood, & Murphy, 
2014). 
It is difficult to blind 
participants receiving an 
mHealth intervention due to the 
physical presence of the device 




The sample size must be 
large enough to eliminate 
chance (Kendall, 2003). 
The sample size required in a 
CEEBIT methodology is 
considerably reduced due to a 
more liberal Type I error rate 
of 50% (Mohr et al., 2013). 
Interaction effect sizes tend to be 
small, making it important to 
ensure that there is sufficient 
statistical power to test any 
interactions that are of particular 
interest (Collins et al., 2007). 
The sample size required will 
depend on the primary aim for the 
trial and the level of analyses. In a 
longitudinal comparison of two 
groups, the sample size 
requirement is identical to that of 
a two-group, longitudinal RCT 
(Almirall et al., 2014). 
Recruiting adequate numbers 
may be challenging in 
developing countries where 
cultural and religious barriers 
may resist technological 





 RCT Characteristics CEEBIT Characteristics MOST Characteristics SMART Characteristics mHealth Challenges 
Cost RCTs are expensive to 
carry out (Comstock, 2012) 
often due to the large 
sample size and length of 
follow-up time required 
(Rosen, Manor, Engelhard, 
& Zucker, 2006).  
The reduced sample size and 
rapid, real-time evaluation 
may contribute to lower 
financial costs than other 
methodologies. 
MOST does not directly assess 
the overall effectiveness of the 
intervention to a comparative 
treatment or control condition 
but the process does ensure that 
the most efficacious version of 
the intervention goes forward to 
the final testing stage, thereby 
making for a more efficient use 
of time and resources (Clough et 
al., 2015). 
It would be more cost-effective 
both in terms of dollars spent, and 
in terms of the value of scientific 
information gained to use the 
SMART methodology, than to 
use a RCT to evaluate each 
question in the SMART stages 
(Almirall et al., 2014). 
In low-income countries where 
there may not be the resources to 
carry out expensive trials 
(Rosen et al., 2006; World 
Health Organisation, 2012) and 
also in high-income countries 
where the sheer volume of 
mHealth interventions 
available, may mean it is not 
feasable to carry out resource-
intensive evaluations. 
Protocol Rigid protocol, designed 
for the elimination of bias 
and confounding factors 
(Pham et al., 2016b). 
Protocol is fluid, allowing for 
consumer choice to be 
incorporated into the 
evaluation as a fully observed 
pre-randomization factor 
(Mohr et al., 2013). 
Protocol is fluid, exact details 
about its implementation depend 
on the application (Collins et al., 
2007). It is a “general approach,” 
rather than an off-the-shelf 
procedure (Collins, Baker, 
Mermelstein, Piper, Jorenby, 
Smith, Christiansen, Schlam, 
Cook, & Fiore, 2011a). 
SMART designs are not, as per 
common misconceptions, 
“adaptive trial designs,” they are 
a fixed study design (Almirall et 
al., 2012; Almirall et al., 2014). 
Software is meant to evolve, 
change and progress over time 
at a rapid pace (Ben-Zeev et al., 
2015). 
Time RCTs are notoriously long 
(Pham et al., 2016b), with 
the entire process, 
including funding 
proposals and publication, 
taking upto 17 years (Mohr 
et al., 2013; Pagoto & 
Bennett, 2013). 
CEEBIT can support the rapid 
evaluation of BITs in near-real 
time through deployment sites 
located in care-providing 
organizations or commercial 
market places with the aim of 
protecting consumers from 
ineffective or inferior BITs 
(Mohr et al., 2013).  
A challenge is whether a full 
cycle of MOST can be 
completed within the five-year 
duration of the typical National 
Institutes of Health (NIH) 
funding cycle (Collins et al., 
2011a). 
The overarching aim of a 
SMART is to construct a high 
quality adaptive intervention 
based on data (Almirall et al., 
2014). This may save resources 
in the long run as the end 
intervention will be already 
optimized. 
In the mHealth field, the fast 
pace at which technology 
evolves, may make lengthy 
study designs unsuitable for 
evaluation as in the time it takes 
to design and evaluate an 
intervention, the mHealth space 
may move so fast that the 
intervention is obsolete before it 
has even been implemented 






There are a number of factors which must be taken into account when selecting an evaluation 
method for a mHealth intervention. This study has suggested six of these factors, identified as 
important from recent literature surrounding the challenges and unique characteristics of mHealth 
evaluations. The mHealth literature widely suggests that a mixed-methods approach should be 
used when evaluating a mHealth intervention (Chib et al., 2014). Quantitative data is important to 
determine if, and to what extent an intervention is functional and beneficial, but because of the 
many socio-technical aspects of mHealth, failing to include a qualitative evaluation may mean that 
the intervention will fail to be implemented and sustained (Chib et al., 2014). These sociotechnical 
factors include the social, cultural, religious and behavioral interactions of the end user, as well as 
other technological issues (Chib et al., 2014), such as adequate cellular service and charging points, 
an issue which is particularly important in LMICs. The data collection of a standard RCT is 
quantitative, and therefore is unable to isolate the socio-technical aspects of mHealth which are so 
important for their successful implementation (Pham et al., 2016b). In addition, the 
inclusion/exclusion criteria employed in RCTs can produce high internal validity but may produce 
poor external validity, impacting the effectiveness of interventions in a “real-world” setting 
(Clough et al., 2015). The CEEBIT method has the potential to include a qualitative aspect but the 
selection of outcome measures will depend on whether the research question primarily pertains to 
the efficacy or the effectiveness of the intervention (Clough et al., 2015). However, if a researcher 
is primarily concerned with the efficacy of an intervention, it could be possible that a qualitative 
evaluation will be absent and compromise the implementation of the intervention. Similarly, the 
MOST method consists of three phases, each of which addresses a different set of questions about 





intervention being evaluated in a RCT. Although the SMART trial follows a quantitative 
methodology, the pilot SMART trial can include qualitative aspects such as focus groups or 
interviews to help uncover new and potentially important tailoring variables (Almirall et al., 2012). 
All of the methodologies outlined in Table 1 include a randomization process. Randomization is 
used to eliminate certain biases and confounding factors and therefore allows a high level of 
confidence to be placed on the results. The randomizations in SMART allow unbiased 
comparisons between treatment components at each decision stage in their development  (Almirall 
et al., 2014). As outlined, there is a difficulty in blinding recipients of a mHealth intervention due 
to the physical presence of the device but the SMART trial suggests the use of an independent 
evaluator who is blind to treatment assignment to eliminate any information bias which may result 
(Almirall et al., 2014). This is important because a lack of blinding in a study design could lead to 
an over-estimation of the effects of an intervention, as was illustrated by Colditz, Miller, and 
Mosteller (1989) who found that medical interventions evaluated within randomized trials that did 
not use a double-blind design reported a significantly greater likelihood of success on average than 
the studies that used double blinding.  
A large sample size may be problematic in the area of mHealth, particularly in low- and middle-
income countries where there may be cultural and religious barriers to technology, resisting change 
and creating challenges with recruitment (Tariq et al., 2011) as well as technological barriers which 
may prevent usage such as intermittent reception and unreliable electricity for charging of devices. 
RCTs require a relatively large sample size in order to eliminate chance (Kendall, 2003), MOST 
requires a large enough sample size to detect small variations in interaction effects with sufficient 
statistical power (Collins et al., 2007) and SMART claims to require a sample size similar to that 





sample size. However, CEEBIT claims to require a much smaller sample size due to its Type 1 
error rate of 50%, compared to the standard Type 1 error rate of 5%.  
RCTs are notoriously expensive (Comstock, 2012), rendering them potentially unsuitable for 
LMICs where financial resources are scarce (Rosen et al., 2006; Frethein, Witter, Lindahl, & 
Olsen, 2012), or even in a developed country, given the sheer volume of mHealth interventions 
currently requiring evaluation, as outlined earlier. The MOST and SMART methodologies both 
suggest greater cost-effectiveness than RCTs as they ensure that the most efficient, fully optimized 
version of the intervention is going forward to be tested in a RCT (Almirall et al., 2012; Clough et 
al., 2015) and the use of MOST does not require more resources than the classical approach 
(Kugler, Balantekin, Birch, & Savage, 2016). Although it could be argued that because these 
methodologies still require RCT evaluation, they are equally as expensive, but the typical cycle of 
intervention-RCT-post hoc analyses-revision of intervention-RCT considerably increases the 
length of time the intervention spends in development (Collins et al., 2007). By presenting an 
optimized intervention for RCT, both financial and time resources can be saved because the 
traditional RCT evaluates the intervention only as a whole, as opposed to evaluating the individual 
components in isolation (Collins et al., 2007). In contrast to the RCT, which aims to evaluate an 
already developed intervention, SMART aims to develop an adaptive intervention based on data 
(Almirall et al., 2014).  
Timing is an important factor in the evaluation of mHealth interventions given how fast technology 
evolves and develops. This is illustrated in the exponential growth and change to the field of 
mHealth which has occurred in the last decade. The RCT process is typically lengthy, taking 5.5 
years on average to complete (Pham et al., 2016b) and there is the risk that a mHealth intervention 





issue, evaluating interventions in near real-time through constant deployment (Mohr et al., 2013). 
The MOST methodology faces challenges as to whether a full cycle can be completed within the 
typical NIH funding cycle (Collins et al., 2011a). Although as Collins et al. (2011a) argue, this 
five-year funding cycle is merely an administrative necessity with no intrinsic scientific meaning 
or merit. However, it may still be incompatible with the speed at which the field of mHealth 
develops. As mentioned previously, a relatively short period of time in the context of drug 
development and trialing equates to a very long period of time in the mHealth field and the MOST 
methodology may be, similarly to the RCT, regarded as too long for mHealth. 
This research aims to answer the research question: “How can we characterize popular evaluation 
approaches to mHealth evaluation and what gaps exist in these approaches ?” We found that of 
the four evaluation techniques presented in this paper, each has many benefits in the context of a 
mHealth evaluation. However there are several gaps in their strengths, particularly in terms of time 
and cost, both of which are critical in LMICs with limited resources. Although none of the 
methodologies include mixed-method components, there is the potential for qualitative evaluation 
to be included in their design. The RCT is hindered by its high cost, and large sample size, but 
MOST and SMART go some way in filling this gap by allowing for the use of smaller sample 
sizes using fractional factorial designs. Similarly, the cost of a RCT is high, and although the 
MOST and SMART methods do recommend eventual evaluation in a RCT, the presentation of a 
final product that is optimized may save costs in the long run. Time appears to be a common issue 
across the evaluation techniques, except CEEBIT, which allows for fast deployment of 
interventions, coupled with a much smaller sample size. We present three examples of the 
application of MOST, SMART and CEEBIT in the evaluation of interventions, as an indication of 





few applied examples of these methodologies were identified in the mHealth literature. The three 
following examples were chosen as they present constructive feedback on the application of each 
methodology, in mHealth or similar fields. We present these in an attempt to help us to understand 
how the alternative methodologies may be used in a mHealth evaluation.  
The Prevention of Substance Use in College Students - MOST 
The MOST methodology was applied during the development of an online intervention for the 
prevention of substance use among college student-athletes (Wyrick, Rulison, Fearnow-Kenney, 
Milroy, & Collins, 2014). The authors applied MOST after running an initial pilot of their program 
using the classic “treatment package” approach. They used MOST to optimize the lesson 
components of the intervention. The final optimized version of the intervention was then evaluated 
in a RCT with the original version as the comparison group. The authors reported the primary 
challenge as having to break the existing intervention into components that could be separated and 
tested. They argue that the optimization phase does not require an unusually large sample size, as 
factorial and fractional factorial experimental designs are used. However, they acknowledged that 
because they used an iterative approach involving three experiments, that the total sample size did 
amount to a larger sample than that required by a RCT. Given the time restraints, they were unable 
to follow students for an extended period of time, suggesting that the approach may be unsuitable 
for outcomes that cannot be captured in a short time-frame. However, the longer term RCT 
evaluation will be able to measure these. The author’s state that MOST efficiently uses scarce 
financial and participant resources, but the iterative process of intervention improvement will 
always be time-constrained (Wyrick et al., 2014).    





An applied example of the SMART methodology for mHealth evaluation was unavailable, but we 
identified one case study comparing a SMART study with traditional RCTs. Moodie, Karran, and 
Shortreed (2016) compared the Clinical Antipsychotic Trials of Intervention Effectiveness 
(CATIE) SMART study with traditional RCTs. CATIE was a multisite study designed to evaluate 
the effectiveness of antipsychotic treatment strategies for patients with schizophrenia. They found 
that SMARTs allow the possibility of studying treatment interactions and delayed effects so may 
provide a “real-world” assessment of treatment sequences than RCTs. The study also had a very 
low risk of bias, and the retention rate was higher than those typically observed in RCTs. However, 
they did not find evidence to suggest greater generalizability when using SMART (Moodie et al., 
2016). Although there is a lack of literature documenting the application of SMART for mHealth 
intervention, their use in multi-component interventions is promising, and could be applied to 
mHealth (Kumar et al., 2013). 
Continual Evaluation of a Smartphone Application for Anxiety in Adults - CEEBIT 
A hypothetical application of the use of CEEBIT is presented in an evaluation of the PsychAssist 
app by Clough et al. (2015). PsychAssist aims to assist in the treatment of anxiety in adults. The 
authors use a 50% alpha rate based on the assumption that there will be symmetry of preference 
among the deployed versions. This sample size results in a smaller required sample size, enabling 
faster testing, dissemination and elimination of inferior versions. Consumers are protected against 
prolonged use of an inferior version as a-priori rules are established to determine which versions 
to eliminate. The authors chose a clinical outcome to determine inferiority, but acknowledged that 
other outcomes such as usage or satisfaction could also be used. The authors argue that CEEBIT 
is well designed to keep pace with the evolving nature and speed of development of mHealth 






To determine the success of a mHealth intervention, evaluation should examine user feedback, the 
robustness of the technology, user engagement strategies, user interaction, safety and accuracy 
(White et al., 2017). Additionally, to ensure that mHealth interventions have the maximum impact 
on healthcare worldwide, evaluation must be cost-effective, using an evaluation technique which 
is fit-for-purpose and allows resources to be used in the most efficient way. The comparison of the 
RCT, CEEBIT, MOST and SMART methodologies shows that each approach is capable of 
examining a number of these factors. However, it is apparent that the methodologies discussed are 
unable to examine all elements simultaneously within the strict time constraints imposed by the 
rapidly evolving field of mHealth. This may mean that, particularly in LMICs, that mHealth 
interventions are not able to fulfil their potential impact on socio-economic development. mHealth 
has the potential to overcome physical and social barriers to healthcare access, empowering 
patients, and allowing them to take a more active role in their health. However, without thorough 
and timely evaluations, the true potential of mHealth across healthcare, social and economic 
environments cannot be realized and harnessed.  
The identification and use of an effective tool for mHealth evaluation will have a far-reaching 
impact, benefitting those in mHealth development and research, strengthening system developer’s 
ability to adequately plan and project the costs, and the length of time required to evaluate their 
intervention. Additionally, as the regulatory landscape of mHealth evolves, those responsible will 
have the tools to make more informed decisions regarding the safety and effectiveness of publicly 
available interventions. Funders will be able to prioritize projects which have clear, effective 
evaluation plans in place and policy makers will be supported in their decision-making (Mechael 





which disease areas, which populations and which interventions (Baltussen & Niessen, 2006; 
World Health Organization, 2017). In the context of mHealth, the challenge lies in the vast number 
of new interventions available for a myriad of health problems. Healthcare policy makers and 
health researchers have different goals, languages and attitudes towards information (Choi, Pang, 
Lin, Puska, Sherman, Goddard, Ackland, Sainsbury, Stachenko, Morrison, & Clottey, 2005). 
Healthcare policy makers are concerned with maximizing population health with interventions that 
are evidence-based, cost effective, and equitable. The evidence for which is produced by health 
researchers (Clancy, Glied, & Lurie, 2012). However, each of these aspects are based on a single 
criteria, making it difficult to prioritize one agenda. Policy makers need to make choices taking 
into account multiple criteria simultaneously. There is a documented lack of economic evaluations 
on mHealth interventions, particularly in LMICs, and this is a barrier to implementation and 
limited policy investment (Iribarren, Cato, Falzon, & Stone, 2017). Studies which have taken an 
economic approach consistently indicate that the socio-economic benefits of health research 
broadly exceed the research costs (Roback et al., 2011). However, conducting mHealth evaluations 
which are ineffective may result in wasted resources, thereby diluting the socio-economic 
development impact of mHealth 
This research serves as a useful first step toward developing an evaluation technique which 
incorporates a multi-criteria decision making tool for policy makers to use in prioritizing mHealth 
interventions. The use of such a tool would provide a focus on providing data which is most 
valuable to decision-makers and ensure that social preferences, epidemiological priorities and 
ethical values are not neglected in the decision making process (Drake, de Hart, Monleón, Toro, 
& Valentim, 2017). It would offer a structured and transparent approach to identify an intervention 





transparency, consistency and accountability of decision making (Adunlin, Diaby, & Xiao, 2015; 
Thokala, Devlin, Marsh, Baltussen, Boysen, Kalo, Longrenn, Mussen, Peacock, Watkins, & 
Ijzerman, 2016).  
This investigation has limitations; the evaluation methodologies have been described in their 
simplest, pure state and the observations made apply only to those. Evaluation methodologies are 
adapted to suit the context in which they are being carried out and these context-dependent 
adaptations have not been taken into account in the above comparison. It was possible to examine 
only the most common evaluation methodologies and it is possible that this comparison of 
evaluation methodologies against mHealth criteria is not exhaustive. Further investigation should 
examine the contextual adaptations applied to the RCT, CEEBIT, MOST and SMART 
methodologies and the potential of these adaptations to produce a better fit for mHealth evaluation. 
Additionally, due to time and resources constraints, we were unable to compare other, less 
frequently mentioned methodologies against the mHealth criteria. There is further scope to assess 
the suitability of adapted methodologies, such as the n-of-1, and the stepped wedge trial, as well 
as the MARS scale for evaluating mHealth interventions.  
Contributions and Future Recommendations 
This study has identified a set of criteria, important to mHealth evaluation, by which existing 
evaluation methodologies can be compared against. These criteria have been determined as 
important in terms of choosing an evaluation technique as they examine both protocol-related 
factors and logistical, resource requirement factors such as time and cost. Further, we have 
demonstrated that the methodologies discussed in this study are unable to simultaneously examine 
all elements of mHealth evaluation, within the strict time constraints imposed by the rapidly 





evaluations and the methodologies currently available. These mismatches will inform future 
research into the development of a fit-for-purpose evaluation technique. An evaluation technique 
that is fit-for-purpose will allow for timely and economical evaluation of mHealth interventions.  
The development of a fit-for-purpose evaluation technique for mHealth will ease the strain on 
regulating bodies as they struggle to deal with the volume of untested mHealth interventions. A 
fast, reliable and cost-effective method of evaluation will allow for high-quality mHealth 
interventions to reach beyond the pilot stage, and lessen the plague of “pilotitis” which is 
hampering progress of the field. Meeting the complex criteria for effective mHealth evaluation 
will strengthen the ability of policy makers to make confident funding decisions when faced with 
the vast number of mHealth interventions being proposed. Additionally, planning for the use of a 
fit-for-purpose technique in the evaluation in a mHealth project will allow research teams to submit 
stronger proposals to funders. 
There is a need for further research into the area of mHealth evaluation to build upon the 
methodologies currently available for the assessment of mHealth interventions. The mismatches 
between the mHealth criteria and the evaluation methodologies must be addressed to allow for the 
development of a holistic approach that will allow evaluations of mHealth interventions to provide 
the most robust and thorough results and contribute to timely, successful and long-term mHealth 
implementation. 
A potential next step toward the development of a fit-for-purpose mHealth evaluation technique 
could be the development of a detailed decision model. Such a model could be used in practice to 
assess which of the currently available evaluation techniques are most suitable for the mHealth 
intervention under evaluation. As previously discussed, a multi-criteria decision model for 





of evaluation, increasing confidence in the field. The development of such a model would allow 
regulatory bodies to more clearly outline which types of mHealth fall under their remit, and as 
such, which evaluation technique they require to meet standards. Additionally, mHealth project 
teams following a decision model will be able to strengthen applications for funding by complying 
with standards. Finally, policy makers and governments will be able to make strong, confident 
decisions about the funding of mHealth interventions that have been evaluated using a decision 
model. 
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